174 related articles for article (PubMed ID: 35488355)
1. Aggressive giant prolactinoma: a case report.
Borhan MK; Tan FHS
J Med Case Rep; 2022 Apr; 16(1):170. PubMed ID: 35488355
[TBL] [Abstract][Full Text] [Related]
2. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
Phillips J; East HE; French SE; Melcescu E; Hamilton RD; Nicholas WC; Fratkin JF; Parent AD; Luzardo G; Koch CA
Hormones (Athens); 2012; 11(4):477-82. PubMed ID: 23422771
[TBL] [Abstract][Full Text] [Related]
3. Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.
Bettencourt-Silva R; Queirós J; Pereira J; Carvalho D
J Med Case Rep; 2018 Dec; 12(1):360. PubMed ID: 30518416
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
Strowd RE; Salvatori R; Laterra JJ
J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
[TBL] [Abstract][Full Text] [Related]
5. Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report.
Koguchi M; Nakahara Y; Ebashi R; Ogata A; Shimokawa S; Masuoka J; Abe T
J Med Case Rep; 2019 Jan; 13(1):18. PubMed ID: 30660191
[TBL] [Abstract][Full Text] [Related]
6. A rare case of a giant prolactinoma with atypical histological features: 5 years of follow-up.
Vasilakis IA; Paltoglou G; Gavra M; Charmandari E
Hormones (Athens); 2022 Jun; 21(2):323-327. PubMed ID: 35143036
[TBL] [Abstract][Full Text] [Related]
7. [Atypical presentation of a giant prolactinoma in a 15-year-old boy].
Vaiani E; Morales C; Soto F; Blanco Y; Rugilo C; Ciaccio M; Belgorosky A
Arch Argent Pediatr; 2018 Apr; 116(2):e325-e330. PubMed ID: 29557627
[TBL] [Abstract][Full Text] [Related]
8. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?
Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G
Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630
[TBL] [Abstract][Full Text] [Related]
9. A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature.
Li D; Wang Y; Tan H; Luo P; Yu Y
BMC Endocr Disord; 2023 May; 23(1):107. PubMed ID: 37173679
[TBL] [Abstract][Full Text] [Related]
10. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
[TBL] [Abstract][Full Text] [Related]
11. Prolactinomas in males: any differences?
Duskin-Bitan H; Shimon I
Pituitary; 2020 Feb; 23(1):52-57. PubMed ID: 31802331
[TBL] [Abstract][Full Text] [Related]
12. Invasive Giant Prolactinoma.
Alkhaibary A; Alharbi A; Khairy S
World Neurosurg; 2024 Jan; 181():21-22. PubMed ID: 37827431
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
14. Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.
Dhanwal DK; Sharma AK
Pituitary; 2011 Dec; 14(4):384-7. PubMed ID: 19381817
[TBL] [Abstract][Full Text] [Related]
15. Giant prolactinoma and effectiveness of medical management.
Acharya SV; Gopal RA; Menon PS; Bandgar TR; Shah NS
Endocr Pract; 2010; 16(1):42-6. PubMed ID: 19703803
[TBL] [Abstract][Full Text] [Related]
16. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
[TBL] [Abstract][Full Text] [Related]
17. Pituitary apoplexy of a giant prolactinoma during pregnancy.
Khaldi S; Saad G; Elfekih H; Ben Abdelkrim A; Ach T; Kacem M; Chaieb M; Maaroufi A; Hasni Y; Ach K
Gynecol Endocrinol; 2021 Sep; 37(9):863-866. PubMed ID: 34124989
[TBL] [Abstract][Full Text] [Related]
18. Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.
Hoffmann A; Adelmann S; Lohle K; Claviez A; Müller HL
Eur J Pediatr; 2018 Jan; 177(1):125-132. PubMed ID: 29168011
[TBL] [Abstract][Full Text] [Related]
19. Absence of hypogonadism in a male patient with a giant prolactinoma: a clinical paradox.
Tamagno G; Daly AF; Deprez M; Vroonen L; Andris C; Martin D; Beckers A
Ann Endocrinol (Paris); 2008 Feb; 69(1):47-52. PubMed ID: 18082643
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor.
Ceccato F; Lombardi G; Albiger N; Mazzai L; Pambuku A; Rolma G; Zagonel V; Scaroni C
Anticancer Drugs; 2019 Jun; 30(5):533-536. PubMed ID: 30986806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]